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11 INTRODUCTION 
A still increasing number of low molecular mass 
GTP-binding proteins with M, values of about 20 000 
have been reco~3nized in recent years. The best'studied 
is the ras protein family, which has been the focus of ill- 
tense research for several years because mutant alleles 
are frequently observed in some human tumors [1], 
Other members of this family that are related to ras arc 
the ral [21, rap [3], tab [4] the [5], and rac [6] gene 
families. The encoded proteins all share the ability to 
bind GTP and GDP with high affinity. They are ap- 
parently active in the GTP-bound form and inactive 
after hydrolysis of GTP to GDP caused by an intrinsic 
GTPase activity of the proteins [1]. 
Many GTP-binding proteins are known to be 
substrates for bacterial ADP-ribosyltransferases and 
the enzymes have been useful tools in analysing the 
functions of these proteins. Whereas G-proteins (G.~, 
Gi, Go, Gt) are ADP-ribosylated by cholera and per- 
tussis to×ins [7], low molecular weight GTP-binding 
proteins are not substrates for these to×ins. Recently, 
however, the the A, B, C [8-11], and rac 1, 2 [6] pro- 
teins have been shown to be substrates for the ADP- 
ribosyltransferase C3 from Clostridium botulinum 
[12-15]. So far, the cellular functions of the the and rac 
proteins and the physiological consequences of their 
ADP-ribosylation are, however, largely obscure. 
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Wc have attempted toanalyse the function of the IqlO 
protein using a ) (enof l l t s  oocyte  system. Fully grown 
Xenoptts oocytcs are physiologic.'tlly arrested in the pro- 
phase of the first meiotic division. Progesterone and in- 
sulin induce the so.called maturation of oocytes with 
progression through the meiotic divisions and arrest at 
metaphase 1I. Low molecular weight GTP-binding pro- 
teins apparently participate in the regulation of oocyte 
maturation. Micro|nice|ion of ras proteins into oocytes 
for example can induce maturation [16] whereas 
monoclonal anti-ras antibody was shown to inhibit 
insulin-induced oocyte maturation [17]. Furthermore, 
microinjection of C. botulinunt ADP-ribosyltrans- 
ferase C3 into oocytes reportedly accelerates the pro- 
gesterone-induced maturation [11]. Consequently, we 
now studied the effects of microinjection of recombi- 
nant the proteins into Xenopus oocytes. 
2. MATERIALS AND METHODS 
2, I, Materials 
Botulinum ADP.ribosyltransferase C3 was purified as described 
[14], Normal and Val-14 rho A cDNAs containing a Hpal site 
engineered at codon 25 [18] were xpressed in E, col| by using an ex- 
pressing system as described earlier [19]. Partial purification of the 
rho proteins (30-50070 pure) were achieved by using DEAE-SeDhacel 
anion-exchange c!~romatngraphy and G75 Sephadex gel permeation 
chromatography as described for ras proteins [19]. Lovastatin was a 
generous gift from Merck, Sharp and Dohme (Munich, FRG) 
[azPINAD was purchased from NEN (Dreieich, FRG). All other 
chemicals were analytical grade and purchased from commercial 
sources .  
2.2. Microinjeetion into Xenopus oocytes 
Stage VI ooeytes from Xenopus laevis were selected after col- 
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3. RESULTS 
It has beez, reported that microinjection of C. 
botttlinutrt ADP-ribosyltransferase C3 accelerates the 
progesterone-induced maturation of Xettoptts ooeytes 
[15]. We have confirmed this finding and observed that 
under control conditions where 50°70 of the oocytes 
underwent maturation after 16.5 h, microinjection of 
C3 shortened this period to about 10 h (not shown). As 
C3 ADP-ribosylates the GTP-binding protein rho, we 
were prompted to study the effect of persistently active 
Val-14 rho protein on the progesterone-induced 
maturation. Surprisingly, microinjection of Val-14 rho 
protein completely changed the morphology of the 
oocytes (Fig. IC). While normal maturation (germinal 
vesicle breakdown) was indicated by the occurrence of 
a white spot in the animal pole (Fig. IB), the Val-14 rho 
protein preparation caused a dramatic redistribution of 
pigments of the animal pole. At first, lamellar white 
segments occurred at the animal pole, which then in- 
creased in size, became confluent and finally resulted in 
a spotted animal pole. This phenotype was not observed 
after microi?,jection of normal rho protein. As shown 
in Fig. 2, the appearance of the morphological changes 
by Val-14 rho protein clearly depended on the presence 
I 
Ci 
Fig. I. Morphological alterations induced by n~icroinjection of Val.14 
l~21rh,, A. A'ellOl;tts oocytes were microinjected with 10 118 Val.14 
p21rht, A and incubated for I 11. Thereafter, the oocytes were 
stimulated for 1 h in a medium containing progesterone (10/~M) and 
then further incubated without the hormone. CA) Control oocytes in- 
cubated without progesterone. (B) Maturated oocytes after stimula. 
tion with progesteroi, e for 1 h and incubation for 16 tl. (C) Oocytes 
microinjected with valine.14 p21 rh*' '~ and treated with progesterone 
for 1 h and incubated for further 4 h. 
of progesterone. Progesterone decreased the time lag 
and increased the rate of appearance of the rho-induced 
oocyte alterations. However, even at the highest con- 
centration of progesterone, the morphological changes 
occurred not earlier than about 1 h after microinjection 
of Val-14 rho. 
Fig. 3 shows that prior ADP-ribosylation of Vai-14 
rho by C3 inhibited its potential to cause morphological 
changes. Under the conditions used, only about 40°/o of 
the rho protein was modified, which might explain why 
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ADP-ribosylatioa delayed the onset of the mor- 
phological changes but did not completely inhibit the 
Val-14 p21rho-indueed effects. 
It has been shown that the biological activity of the 
ras proteins depends on their ,association with the 
plasma membrane. We studied whether the injected rho 
protein was associated with the ooeyte membrane. 
Therefore, Val-14 p21rho-mieroinjected oocytes were 
incubated for various periods of time and, thereafter, 
separated into soluble and membrane fractions. The 
presence of the the protein was determined by 
['uP]ADP-ribosylation with C3. Under control eondi. 
tion, e.g. without mieroinjeetion, C3 slightly labeled a 
20 kDa protein in the membrane fraction, h~ contrast, 
after mieroinjection an increase in labeling of more 
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jection of Val. 14 rho A i~l'Otchl, o0~..yl~ 'd, erc ill~ub:tted without (A) 
and with (B) Iova~t;ttin (see ~ection 21 for the ilidieated ilel'ioti~ of 
liilic, Then tile sohlble (S) auld tl'letYd)ran¢ fr;t~:lon~ tl )) of oocyt¢~ 
were SCl~;tr:lled aild Al~li.ribosyl;.tted by (."3 whh O, I tim [~"I)INAI), 
The hibeled i~l'otein'~ were :lnllly.~ed by .~I)S-I):%(II{ itltd ;n i torad io .  
gr;il~hY (~lioWl;), (,.'olil cciil lrol,,, not Inicroinj¢~:led), 
than 10.fold occurred. As shown in Fig. 4A, 5 mid 15 
rain after microinjection the labeled protein was observ- 
ed in the soluble fraction, while at time point 30 rain 
and later the major  labeling was determined in the 
membrane fraction. The ADP-ribosyl;tted protein of 
the supernatant migrated a little slower than that iJ~ the 
pellet fraction. In contrast, when the cells were treated 
with lovastatin, an inhibitor of  the mevalonic acid 
pathway, no transloeation of  the the protein into the 
membrane was detected (Fig. 4B). F ig.  5 shows that 
treatment of oocytes with lovastatin also inhibited the 
morphological changes induced by Val-14 p21 the. Fur- 
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Fig. 3, Impairment of the effect of Va ld4 p2l rt~° A by ADP- 
ribosylation with C3. Val.14 p21 rh° A was ADP-ribosylated in the 
absence (*) and presence (A) of NAD by C3 as described in section 
2; thereafter, the pretreated proteins were microinjected and the 
oocytes stimulated b~,progesterone (10 pM) for the indicated inter- 
vals. 
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Fig. 5. Influence of lovastatin on the effects ofVal-14 I32 l'h° A protein 
in Xenopus oocytes. Xenopus oocytes were preincubated without (.) 
and witl~ lovastatin (200 v.M; A ) and lovastatin plus mevalonic acid 
(0.8 raM; [] ) for I h, then 10 ng Val-14 p21 the a was microinjected and 
the incubation was continued for 1 h. Thereafter, the oocytes w~re
stimulated for 1 h by progesterone (t0 p.M) and further incubated 
without the hormone. At the indicated periods of time the mor- 
phologically altered oocytes were scored. 
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,I, I)ISCUSSION 
We report here thut microinjcctiou of pcrsist¢ittly ac- 
tive Val-14 rho r¢COlllbillalll prot¢ill ¢£tuscs dralllatic 
¢lumt~es in the morDhulogy of Xcm~pus ootytes 
characterized by redistrilmtion of the pisnlented half of 
the o0cytes. Appm'clttly, tllc efl'cct of the mutant rho 
protein dope[ideal ou the imsltranshttionnl isoprcnyla- 
tion of the rho protein, since Iovastatin imlmircd the ac- 
tion of Val-14 rho protein on ifig,nent rc+.li,~tribution f 
oocytes, an effect which was restored by addition of 
rnevalonic acid. l,,ovast:ttin is a 3-11ydroxy-3-methyl- 
glutaryl COellZyllle A reductase inhibitor, which blocks 
the fornlation of mevalonic acid, a precursor of 
isoprene residues [21], Recently it has been demon. 
strafed that all ras proteins aic isoprenylated at 
cyst~ine-186 after protctllytic cleavage o f thi'ce aniino 
acids of the C-termilllIl CAAX motif [24]. '['his 
modification is apparently essential for the biological 
activity uf the ras proteins. The rho proteins possess the 
same C-terminal motif [25,26]. Our findings are in 
agreement with the view that the rho proteins are also 
subject o ;soprenylation. Isoprenylation i creases the 
hydrophobicity of the protein, which most likely is a 
prerequisite for the association of the protein with the 
plasma membrane and for its full biological activity. 
Prior ADP-ribosylation of Val-14 rho by C3 im- 
paired the activity of the GTP-binding protein in 
Xenopus oocytes. A similar result was recently obtained 
with ADP-ribosylated rho protein microinjected into 
3T3 NIH cells. C3 modifies the rho protein at 
asparagine-41 [27]. Deduced from the 3-dimensional 
model of ras [28] and provided a high structural 
homology between ras and rho, the ADP-ribose- 
acceptor in rho is located in the so-called effector egion 
of the GTP-binding protein which might explain why 
ADP.ribosylation renders the protein inactive. 
The effects of the Val-14 rho protein on oocytes 
depends on the presence of progesterone. Progesterone 
inhibits adenylyl cyclase, decreases the cyclic AMP 
levels of oocytes and causes by a sequelae of further 
events, which are not fully understood, the induction of 
oocyte maturation [29]. Since the induction of matura- 
tion by progesterone has been shown to be accelerated 
by botulinum ADP-ribosyltransferase C3 [15], it may 
be that rho proteins play a tonic regulatory role in 
maturation. 
The precise mechanism by which the activated rho 
protein causes the alterations described here is unclear. 
However, there is evidence that rho is somehow involv- 
ed in the regulation of cytoskeletal elements. For exam- 
ple, treatment of Vero cells or rat hepatome FAO cells 
wit h ('3 ~.,atl,Cs ihc tlcslruclioll of lh~: illi~;rofilnlll¢lZl i1¢1+ 
work  [ I [ ,,~O], ]"tll't II¢1'111o1"¢, IllicroilljC~.li011 ill' C.I in 
Nil[ 3T3 celts in,,iucc,, rtmndiny, up of cells and 
rcdi.,t|'iht|tioll oi + nicrt~filantent proteins ITS], In- 
tcrtslin.qly, injcclit+n of VuI-i.l rlm protein into N IH  
yr3 ceil+, caw, c~ rapid ch.'uWcs in ceil mm'phololly 
chm'acttrizcd by ~oliIraclii+ll of the tell body and for- 
mation of finger.like pro¢cssc~, a phenotyp~ different 
fl'Olll thilt induced by microin,i¢ction of C3 [IS]. It is 
ktloWll Ill;it tile internal sit'tier[ire of ,.~'t'/lOl)tt.s" oocytes is 
I'¢¢~l'b;i.|lliZ¢t.I dul'iil b' the I~r,~gc,qcrone-induced tll;.tttlrll- 
l i on  [31]. We Call spcctil;.tte th;,tt tilt,' t'¢~le of rho hi 
tmcyt:s is tt) I'¢+~,Ulatt. ~ he eytoskelctal Ol'l~;.|lli~,atioll, The 
et+l'ects We observe after ivlit:l'OilljectiOil t+|' VIII.14 rho 
illily [11' a CtJllSeql.l¢llc¢2 of seV¢l'¢ r¢ol'g~.llliZiltiol ! o|' tile 
cytoskcletal i etwtn'k, 
,.lcktlowl,'d.gettl¢llt,~: This work ',~a', '+upl+t+rted by the Sonder. 
f,,'~rs,,:huug,,bereid'1 2N,/, ,Material de,,uril',cd liereln is part of the thesis 
of (',M. 
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